CN105381352A - 一种治疗妇科炎症的外用中药洗液 - Google Patents
一种治疗妇科炎症的外用中药洗液 Download PDFInfo
- Publication number
- CN105381352A CN105381352A CN201510848120.1A CN201510848120A CN105381352A CN 105381352 A CN105381352 A CN 105381352A CN 201510848120 A CN201510848120 A CN 201510848120A CN 105381352 A CN105381352 A CN 105381352A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 206010061218 Inflammation Diseases 0.000 title claims abstract description 20
- 230000004054 inflammatory process Effects 0.000 title claims abstract description 20
- 239000006210 lotion Substances 0.000 title abstract description 10
- 230000000699 topical Effects 0.000 title abstract 4
- 239000007788 liquid Substances 0.000 claims abstract description 30
- 235000009267 Patrinia scabiosaefolia Nutrition 0.000 claims abstract description 10
- 238000005406 washing Methods 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 13
- 241001649190 Campsis Species 0.000 claims description 11
- 229940079593 drugs Drugs 0.000 claims description 11
- 241001447691 Beckmannia eruciformis Species 0.000 claims description 9
- 241000868211 Patrinia scabiosifolia Species 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 abstract description 27
- 230000000694 effects Effects 0.000 abstract description 24
- 244000011358 Patrinia scabiosaefolia Species 0.000 abstract description 8
- 230000001954 sterilising Effects 0.000 abstract description 8
- 230000003110 anti-inflammatory Effects 0.000 abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 230000035876 healing Effects 0.000 abstract description 5
- 231100000486 side effect Toxicity 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 241001546929 Campsis grandiflora Species 0.000 abstract description 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 240000000774 Cunila origanoides Species 0.000 abstract 1
- 235000018274 Cunila origanoides Nutrition 0.000 abstract 1
- 240000006652 Cupressus sempervirens Species 0.000 abstract 1
- 235000014866 Dictamnus albus Nutrition 0.000 abstract 1
- 240000003271 Leonurus japonicus Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 241001146210 Senecio scandens Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000009242 dandelion Nutrition 0.000 abstract 1
- 235000014079 dandelion Nutrition 0.000 abstract 1
- 210000004369 Blood Anatomy 0.000 description 47
- 239000008280 blood Substances 0.000 description 46
- 201000010099 disease Diseases 0.000 description 25
- 239000000243 solution Substances 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 210000001215 Vagina Anatomy 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- IKIIZLYTISPENI-ZFORQUDYSA-N Baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 14
- 210000004185 Liver Anatomy 0.000 description 14
- 231100000614 Poison Toxicity 0.000 description 14
- 230000001717 pathogenic Effects 0.000 description 14
- 210000000952 Spleen Anatomy 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 12
- 206010046914 Vaginal infection Diseases 0.000 description 11
- 230000001737 promoting Effects 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 208000001848 Dysentery Diseases 0.000 description 10
- 208000005679 Eczema Diseases 0.000 description 9
- 206010023126 Jaundice Diseases 0.000 description 9
- 210000000214 Mouth Anatomy 0.000 description 9
- 210000003491 Skin Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 201000004624 dermatitis Diseases 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 210000003734 Kidney Anatomy 0.000 description 8
- 230000003115 biocidal Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 238000004140 cleaning Methods 0.000 description 8
- 201000009910 diseases by infectious agent Diseases 0.000 description 8
- 231100001003 eczema Toxicity 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 229960003321 baicalin Drugs 0.000 description 7
- 244000052769 pathogens Species 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 201000008100 vaginitis Diseases 0.000 description 7
- 206010018987 Haemorrhage Diseases 0.000 description 6
- 210000002784 Stomach Anatomy 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000003628 erosive Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 244000045947 parasites Species 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010027327 Menstrual disease Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 206010037844 Rash Diseases 0.000 description 5
- 230000000249 desinfective Effects 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 101710031899 moon Proteins 0.000 description 5
- 230000003000 nontoxic Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000025627 positive regulation of urine volume Effects 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 210000001015 Abdomen Anatomy 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 210000004392 Genitalia Anatomy 0.000 description 4
- 229960000282 Metronidazole Drugs 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 210000003205 Muscles Anatomy 0.000 description 4
- 210000004915 Pus Anatomy 0.000 description 4
- 206010072736 Rheumatic disease Diseases 0.000 description 4
- 208000005687 Scabies Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 206010068760 Ulcers Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000000844 anti-bacterial Effects 0.000 description 4
- 230000001139 anti-pruritic Effects 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000002147 killing Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 210000004914 menses Anatomy 0.000 description 4
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000000552 rheumatic Effects 0.000 description 4
- 230000035943 smell Effects 0.000 description 4
- 230000002522 swelling Effects 0.000 description 4
- 201000010874 syndrome Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 3
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 3
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 3
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 3
- 208000002894 Beriberi Diseases 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 208000001780 Epistaxis Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 3
- 206010018836 Haematochezia Diseases 0.000 description 3
- 208000000616 Hemoptysis Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 3
- 210000004072 Lung Anatomy 0.000 description 3
- 208000001140 Night Blindness Diseases 0.000 description 3
- FGIUAXJPYTZDNR-UHFFFAOYSA-N Potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010040872 Skin infection Diseases 0.000 description 3
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 3
- 231100000765 Toxin Toxicity 0.000 description 3
- 210000003932 Urinary Bladder Anatomy 0.000 description 3
- 210000002700 Urine Anatomy 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 210000003905 Vulva Anatomy 0.000 description 3
- 208000002003 Vulvitis Diseases 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 231100000319 bleeding Toxicity 0.000 description 3
- 230000000740 bleeding Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000003203 everyday Effects 0.000 description 3
- 230000001605 fetal Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229940079866 intestinal antibiotics Drugs 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000003211 malignant Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 3
- 210000000056 organs Anatomy 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reduced Effects 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000002588 toxic Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- 241001249158 Artemisia verlotiorum Species 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010008323 Cervicitis Diseases 0.000 description 2
- 229960002152 Chlorhexidine Acetate Drugs 0.000 description 2
- 229960001231 Choline Drugs 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000007163 Dermatomycosis Diseases 0.000 description 2
- 241000668709 Dipterocarpus costatus Species 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Exidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 210000000232 Gallbladder Anatomy 0.000 description 2
- 208000006750 Hematuria Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N Inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 229940029339 Inulin Drugs 0.000 description 2
- 229940039696 Lactobacillus Drugs 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 206010029410 Night sweats Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 241000517307 Pediculus humanus Species 0.000 description 2
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 2
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010040943 Skin ulcer Diseases 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N Strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 210000001113 Umbilicus Anatomy 0.000 description 2
- 230000035957 Urine Volume Effects 0.000 description 2
- 208000006374 Uterine Cervicitis Diseases 0.000 description 2
- 229940088594 Vitamin Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001154 acute Effects 0.000 description 2
- 201000000736 amenorrhea Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000003712 anti-aging Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000001488 breeding Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CRBHXDCYXIISFC-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CC[O-] CRBHXDCYXIISFC-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 201000003929 dermatomycosis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000032686 female pregnancy Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001524 infective Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000000968 intestinal Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 201000005505 measles Diseases 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000000050 nutritive Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001047 pyretic Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 210000002229 urogenital system Anatomy 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229930003231 vitamins Natural products 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000003455 Anaphylaxis Diseases 0.000 description 1
- 229940088710 Antibiotic Drugs 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000002479 Balanitis Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 229940095731 Candida albicans Drugs 0.000 description 1
- 206010007134 Candida infection Diseases 0.000 description 1
- 240000000218 Cannabis sativa Species 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 210000003756 Cervix Mucus Anatomy 0.000 description 1
- 210000003679 Cervix Uteri Anatomy 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- MYSWGUAQZAJSOK-UHFFFAOYSA-N Ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 208000006111 Contracture Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 206010014881 Enterobiasis Diseases 0.000 description 1
- 206010014970 Ephelide Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 210000003414 Extremities Anatomy 0.000 description 1
- 206010016286 Febrile disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229940097043 Glucuronic Acid Drugs 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 229940096919 Glycogen Drugs 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010018913 Haemolysis Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 210000003128 Head Anatomy 0.000 description 1
- 208000002287 Hemorrhoids Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010020937 Hypoaesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 210000001503 Joints Anatomy 0.000 description 1
- 241000731961 Juncaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 210000003041 Ligaments Anatomy 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000004396 Mastitis Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028334 Muscle spasms Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 241000283898 Ovis Species 0.000 description 1
- 210000004681 Ovum Anatomy 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 210000003516 Pericardium Anatomy 0.000 description 1
- 210000002826 Placenta Anatomy 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 206010039705 Scleritis Diseases 0.000 description 1
- 210000004706 Scrotum Anatomy 0.000 description 1
- 206010040849 Skin fissure Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010061372 Streptococcal infection Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010042772 Syncope Diseases 0.000 description 1
- 208000006379 Syphilis Diseases 0.000 description 1
- 210000002435 Tendons Anatomy 0.000 description 1
- 235000015450 Tilia cordata Nutrition 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 206010046916 Vaginal inflammation Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 231100000611 Venom Toxicity 0.000 description 1
- 210000001048 Venoms Anatomy 0.000 description 1
- 210000001835 Viscera Anatomy 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000010484 Vulvovaginitis Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000001877 Whooping Cough Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 230000001058 adult Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000003266 anti-allergic Effects 0.000 description 1
- 230000003064 anti-oxidating Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000038129 antigens Human genes 0.000 description 1
- 108091007172 antigens Proteins 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 201000009541 complex regional pain syndrome Diseases 0.000 description 1
- 230000001143 conditioned Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002440 hepatic Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000749 insecticidal Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000009114 investigational therapy Methods 0.000 description 1
- 239000008921 jie er yin Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 201000011442 metachromatic leukodystrophy Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 201000005702 pertussis Diseases 0.000 description 1
- 201000007100 pharyngitis Diseases 0.000 description 1
- 230000024715 positive regulation of secretion Effects 0.000 description 1
- 230000003389 potentiating Effects 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000015330 renal sodium excretion Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001568 sexual Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000002269 spontaneous Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000576 supplementary Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000004642 transportation engineering Methods 0.000 description 1
- 230000000472 traumatic Effects 0.000 description 1
- 238000004450 types of analysis Methods 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N β-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
Abstract
本发明提供了一种治疗妇科炎症的外用中药洗液,所述洗液中各种原料药的重量份数为:百部10~15份,黄柏10~15份,苦参10~15份,地肤子10~15份,白藓皮10~15份,当归10~15份,千里光10~15份,土茯苓10~15份,凌霄花10~15份,紫草10~20份,白及10~20份,益母草10~20份,紫花地丁10~20份,鸡血藤10~20份,蛇床子10~20份,黄花败酱草10~20份,黄芩10~20份,艾叶10~20份,蒲公英10~20份,苍术10~20份。与现有技术相比教,本发明具有止痒迅速,杀菌彻底,消炎除虫效果强,抗炎、止痒效果好;并且给药方便,药液易于制造,成本低廉等优点。且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的保健品,特别涉及一种治疗妇科炎症的外用中药洗液。
背景技术
调查显示,全世界约87%的成年女性不同程度的感染过妇科炎症,临床常见的妇科炎症有阴道炎、宫颈炎、子宫内膜炎等。临床上妇科炎症主要表现为阴道瘙痒、灼热肿痛、白带增多、尿频、尿急、尿痛等症状,反复发作,经久不愈,影响生活质量和夫妻生活。
健康的女性,外阴只用清水清洗即可,阴道内部有自洁功能,不必清洗。如果没病,却天天使用洗液清洁,就会刺激阴道,影响乳酸的分泌,打破正常菌群和酸性环境,从而降低人体的抵抗力。
妇科炎症往往预示着疾病,所以必须正规看医生,并在医生指导下治疗。洗液仅仅是在病症明确之后的辅助保健措施,不可代替医生治疗。现在的医药厂家纷纷推出自己的妇女洗液品牌,其中大多属于中药制剂,能起到杀菌、清洁的作用。
此外,部分妇科洗液中还有以下一些西药成分,主要作用是抑制病菌滋生,维持阴道内正常的弱酸性环境:醋酸氯已定:白色念珠菌,淋病双球菌的抑菌杀菌。醋酸洗必泰:适用于皮肤及粘膜的消毒;创面感染、阴道感染和子宫颈糜烂的冲洗。
外阴炎是妇科常见病,现代医学认为,本病可分为特异性与非特异性感染两种。特异性外阴炎以霉菌、滴虫感染为主,非特异性外阴炎以葡萄球菌、大肠杆菌、链球菌感染等为主,临床以非特异性感染比较多见,此外还可以继发于其他局部或全身疾病,如宫颈炎、阴道炎、宫颈癌等病,因分泌物增多的刺激,或经血、恶露过多过久的刺激,均可引发不同程度的炎症。
女性特殊生理条件致病菌不少以女性阴道为孳生地,可因女性每月内分泌变迁,影响阴道PH条件,有利于这类寄生菌活跃繁殖,数量增多,成为发病要素,产生局部瘙痒,灼热,黏膜红肿,充血,甚而可使黏膜发疹或糜烂。随之刺激阴道分泌物增多,微生物(真菌或滴虫)的产物假膜形成絮状白带,或泡沫样分泌溢出,腥臭味日渐增重。在女性阴道微生物繁殖期间,男女性交,极易成为男性被感染的机会,导致包皮龟头炎的发生。感染局部产生红肿,发疹、糜烂、渗液及灼热、发痒一系列症状。
其中部分患者原发病(如霉菌或滴虫性阴道炎)治愈后,外阴瘙痒症状仍不能缓解。目前西医尚无特效疗法。抗生素治疗妇科的各种生殖泌尿系统炎症及痛经带下等效果很不理想,用西药治疗此类妇科病,不但疗效差、易复发,而且副作用大,又没有特效的中成药。临床以中医师随病证外方作汤剂口服,以及一些中药洗剂,但治疗效果均不甚理想,存在着可诱发耐药性、复发率高、用药不便、制剂困难等不足。而目前已经公开地用于妇科洗液的药物,如:“恩威牌”洁尔阴洗液,仍然不能达到理想的抗炎、止痒效果。
许多患者迫切希望能有一种使用方便而效果好的外用药物,用于防治各种类型的阴道炎症,能达到标本兼治,以内养外,且无毒副作用,使用方便,治愈时间短,治愈后不易复发的妇科洗液。
发明内容
本发明所要解决的技术问题在于,由于阴道特殊结构,妇女平时忽视卫生,或久居阴湿之地,以致湿邪侵入阴道,或情怀不畅,肝郁化火,脾虚生湿,湿热郁注下焦,均可发为阴痒。治疗妇科的西药药物很多,有抗菌药物如甲硝唑、环丙沙星等,微生态治疗制剂如乳酸杆菌、地衣芽孢杆菌。抗生素治疗妇科的各种生殖泌尿系统炎症及痛经带下等效果很不理想,用西药治疗此类妇科病,不但疗效差、易复发,而且副作用大,又没有特效的中成药,临床以中医师随病证外方作汤剂口服,以及一些中药洗剂,但治疗效果均不甚理想,存在着可诱发耐药性、复发率高、用药不便、制剂困难等不足。现在迫切需要提供了一种见效快、副作用小、抑菌性强,止痒杀虫效果迅速的的洗液,能有效解除患者的痛苦,治疗妇科阴道炎症。
为解决上述技术问题,本发明提供了一种治疗妇科炎症的外用中药洗液,所述洗液中各种原料药的重量份数为:百部10~15份,黄柏10~15份,苦参10~15份,地肤子10~15份,白藓皮10~15份,当归10~15份,千里光10~15份,土茯苓10~15份,凌霄花10~15份,紫草10~20份,白及10~20份,益母草10~20份,紫花地丁10~20份,鸡血藤10~20份,蛇床子10~20份,黄花败酱草10~20份,黄芩10~20份,艾叶10~20份,蒲公英10~20份,苍术10~20份。
优选地,其所述洗液中各种原料药的重量份数还可以为:百部10~15份,黄柏10~15份,苦参10~15份,地肤子10~15份,白藓皮10~15份,当归10~15份,千里光10~15份,土茯苓10~15份,凌霄花10~15份,紫草10~15份,白及10~15份,益母草10~15份,紫花地丁10~15份,鸡血藤10~15份,蛇床子10~15份,黄花败酱草10~15份,黄芩10~15份,艾叶10~15份,蒲公英10~15份,苍术10~15份。
为解决上述技术问题,本发明还提供一种治疗妇科炎症的外用中药洗液,其特征在于,所述洗液的制备步骤包括:
a.将所述原料药除白及、艾叶和苍术外放入粉碎机粉碎后过筛,
b.将过筛后剩下的颗粒物放入乙醇中加热回流提取2次;
c.再取上述乙醇提取后的药渣,加水加热回流提取2次;
d.将上述两种提取液合并浓缩;
e.将白及、艾叶和苍术用蒸馏法汽化成白色结晶粉末;
f.将汽化的白色结晶粉末倒入浓缩液中混匀,加甲硝唑溶液搅拌均匀,紫外线消毒后罐装。
所述步骤a中,可以将所述原料药除白及、艾叶和苍术外放入粉碎机粉碎后过100目细筛,使能通过100目筛的细粉量在达到30%,收集通过100目筛的原料细粉备用。
所述步骤b中,可以将过筛后剩下的粗颗粒物放入乙醇中加热回流提取2次,每次1~2小时,将2次提取液合并静置;
所述步骤c中,可以将上述乙醇提取过的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置。
所述步骤d中,可以将上述两种提取液合并,减压浓缩相对密度为80℃时1.37的滤液,回收乙醇,将所得滤液调整比重到1.06,加入过筛的细粉后搅匀。倒入0.5%甲硝唑溶液中。
所述步骤e中,可以将白及、艾叶和苍术用蒸馏法汽化成白色结晶,干燥后成粉末状,收集备用。
所述步骤f中,可以将浓缩的药液加上汽化的白色结晶粉末混匀,倒入0.5%甲硝唑溶液中搅拌均匀,用紫外线消毒后罐装。
治疗采取外洗或坐浴,每次20~30mL,每日2次。一般以10d为1疗程,2~3个疗程后观察疗效。
与现有技术相比教,本发明具有止痒迅速,杀菌彻底,消炎除虫效果强,抗炎、止痒效果好;并且给药方便,药液易于制造,成本低廉等优点。且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。能创造较好的社会价值及经济利益。
具体实施方式
从解剖上来讲,女性的外阴处于一个自然闭合的状态,保证阴道不和外界相通。阴道壁在平时前后壁也是闭合的状态,宫颈也是一个闭合状态。除此以外另外,间接接触传染也是霉菌性阴道炎的一条传播途径。接触哪些物品可能被传染阴道炎接触被霉菌患者感染的共厕所的坐便器、浴盆、浴池坐椅、毛巾,使用不洁卫生纸,都可以造成传播,当被感染者外阴阴道的念珠菌达到一定数量时,即可发生霉菌性外阴阴道炎。其他可导致阴道炎的行为抗菌素、消炎药是罪魁大量服用抗菌素也可以导致阴道炎。只要用了抗生素无论是口服还是打针都会抑制阴道的乳酸杆菌扰乱阴道的自然生态平衡,改变了阴道的微环境,致病的细菌病源体就可能繁殖,最终导致局部的念珠菌性阴道炎发作。所以一般情况下不要大量服用抗菌素类药物。
阴道各种炎症属中医妇科杂病阴痒和带下范畴,两者常相互伴见。阴痒和带下的发生有两方面原因:一方面与内因:肝、肾、脾功能失常关,肝脉绕阴器,又主藏血,为风木之脏;肾主藏精,主生殖,开窍于二阴;脾主运化水湿。如若肝经湿热或肝郁脾虚化火生湿,湿热之邪随经下注,蕴结阴器故而阴痒;或肝肾不足,精血亏虚,生风化燥,阴道肌肤失养,不荣而痒;另外一方面与外因感染湿邪病虫有关,因摄身不慎,致湿邪病虫侵入,虫扰阴道,发为阴痒。《医宗金鉴·妇科心法要诀》所说“妇人阴痒,多因湿热生虫”即是此意。显然,引发感染性阴道炎的原因应属后者。按照传统中医理论,由内因所致者以内服药调整功能为主,而因外感病虫所致者或辅以外治或以外治为主要手段。
由于感染湿邪病虫所致之阴痒、带下者多表现为肝经湿热,因而治疗应以清热除湿、杀虫止痒为原则。本病主要是因湿热蕴结,虫蚀阴中所致湿热之邪有内外之分。如久居湿地等致湿邪外侵,郁而化热,或经期、产后,湿热邪毒乘虚而入,此为外感湿热。若素体脾气虚弱,或肝气郁结,木克脾土,脾失健运,水湿内留,停注下焦,蕴而化热,则为内生湿热。湿热蕴结,韧带不固,则带下增多,色黄。下焦湿热,膀优失约则并发淋证;湿邪浸淫日久成毒,或感染热毒邪气,热盛迫血妄行,或湿毒腐蚀肌肤,则可见带下脓血,或见″阴蚀″、″阴疮″。湿腐生虫,或摄生不慎,虫邪直犯阴器,虫蚀阴中则阴痒,阴中灼痛本病虽病在阴器,但每与肝脾等脏腑有关。多因湿邪为病。显然,引发感染性阴道炎的原因应属后者。
白及性苦、甘、涩,微寒。归肺、肝、胃经。功能主治收敛止血,消肿生肌。用于咳血吐血,外伤出血,疮疡肿毒,皮肤皲裂;肺结核咳血,溃疡病出血。《神农本草经》:“主痈肿、恶疮、败疽,伤阴死肌,胃中邪气”;《本草纲目》:“气味(根)苦、平、无毒。
地肤子清热利湿,祛风止痒。用于小便涩痛、阴痒带下、风疹、湿疹、皮肤瘙痒。《药性论》:″与阳起石同服,主丈夫阴痿不起,补气益力;治阴卵癀疾,去热风,可作汤沐浴。″地肤子煎剂2g/kg给家兔灌胃,6小时内尿中氯化物增加127.1%~131.6%,但总尿量无变化.有报告指出,地肤子对大白鼠尿量及尿钠排出均有影响。
黄柏清热燥湿,泻火除蒸,解毒疗疮。用于湿热泻痢,黄疸,带下,热淋,脚气,痿辟,骨蒸劳热,盗汗,遗精,疮疡肿毒,湿疹瘙痒。盐黄柏滋阴降火。用于阴虚火旺,盗汗骨蒸。《中国药典》载黄柏清热燥湿之力,与黄芩、黄连相似,但以除下焦之湿热为佳。
苦参性苦,寒。归心、肝、胃、大肠、膀胱经清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风;外治霉菌性阴道炎,常与黄柏结合使用,是治疗阴道炎的外用妇科良药。
百部性味甘苦,微温。《别录》:微温。《药性论》:味甘,无毒。《日华子本草》:味苦,无毒。性味甘、苦,微温。归肺经。功能主治润肺下气止咳,杀虫。用于新久咳嗽,肺痨咳嗽,百日咳;外用于头虱,体虱,蛲虫病,阴道骚痒。
白藓皮祛风,燥湿,清热,解毒。治风热疮毒,疥癣,皮肤痒疹,风湿痹痛,黄疸。《本经》:主头风,黄疸,咳逆,淋沥,女子阴中肿痛,湿痹死肌,不可屈伸、起止、行步。
土茯苓性味:甘淡,平。归经:肝经;胃经;脾经。功能:解毒,除湿,利关节。主治:治梅毒,淋浊,筋骨挛痛,脚气,疔疗疮,痈肿,瘰疬。
当归,其味甘而重,故专能补血,其气轻而辛,故又能行血,补中有动,行中有补,诚血中之气药,亦血中之圣药。大约佐之以补则补,故能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。佐之以攻则通,故能祛痛通便,利筋骨,治拘挛、瘫痪、燥、涩等证。营虚而表不解者,佐以柴、葛、麻、桂等剂,大能散表卫热,而表不敛者,佐以大黄之类,又能固表。惟其气辛而动,故欲其静者当避之,性滑善行,大便不固者当避之。凡阴中火盛者,当归能动血,亦非所宜,阴中阳虚者,当归能养血,乃不可少。
黄芩有清热燥湿,凉血安胎,解毒功效。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。黄芩的临床应用抗菌比黄连还好,而且不产生抗药性。我们借助广谱抗菌作用强的特点,用在真菌培养杂菌感染特厉害,用黄芩提取液效果很好。《本草经疏》:黄芩,其性清肃,所以除邪:味苦所以燥湿;阴寒所以胜热,故主诸热。诸热者,邪热与遍热也,黄疸、肠僻、泄痢,皆湿热胜之病也,析其本,则诸病自瘳矣。苦寒能除湿热,所以小肠利而水自逐,源清则流洁也。血闭者,实热在血分,即热人血室,令人经闭不通,湿热解,则荣气清而自行也。恶疮疽蚀者,血热则留结,而为痈肿渍烂也:火疡者,火气伤血也,凉血除热,则自愈也。黄芩有抗变态反应及抗炎作用:黄芩所含黄芩甙与黄芩素能明显抑制致敏豚鼠离体小肠与离体气管对抗原所产生的过敏性收缩反应,对豚鼠与小鼠的被动全身性变态反应以及豚鼠被动性皮肤变态反应,黄芩甙与黄芩素亦有抑制作用。黄芩有解热作用,多数试验证明,黄芩的有效成份黄芩甙元有解热作用。黄芩有解毒作用,黄芩甙有明显的解毒作用,这可能是由于在β-葡萄糖醛酸甙酶的作用下,黄芩甙分解出葡萄糖醛酸,并与多种毒物结合所致。黄芩甙10毫克能提高士的宁的LD50达2.5倍,并且使四氯化碳中毒小鼠的肝糖原含量增多。
益母草味辛苦、凉。活血、祛淤、调经、消水。治疗妇女月经不调,胎漏难产,胞衣不下,产后血晕,瘀血腹痛,崩中漏下,尿血、泻血,痈肿疮疡。益母草碱性皮下注射有中枢抑制作用,MLD为0.4-0.6g/kg。兔静脉注射益母草碱1mg/kg,可见尿量显著增加。益母草碱在较高浓度时能使兔血悬液发生溶血作用。益母草碱水浸液用试管稀释法1∶13-1∶10,对许兰氏毛菌,羊毛样小孢子菌、红色表皮癣菌、星状奴卡氏菌均有抑制作用。益母草煎剂用平板纸片法,对大肠杆菌、志贺氏痢疾杆菌有抑制作用。益母草能去淤生新,活血调经,含有硒、锰等多种微量元素,能抗氧化、防衰老,具有相当不错的益颜美容、抗衰防老功效。
黄花败酱草性味苦平,具有清热解毒、排脓破瘀的功效。能医肠痈、下痢、赤白带下、产后瘀滞腹痛、目赤肿痛。入胃、大肠、肝经。主治清热解毒,消痈排脓,活血行瘀。用于肠痈、肺痈及疮痈肿毒,实热瘀滞所致的胸腹疼痛,产后瘀滞腹痛等症。
凌霄花一种传统中药材,拉丁名Campsisgrandiflora。具有行血去瘀、凉血祛风利湿,清热解毒,味辛酸,性微寒归肝、心包经、功能活血散瘀,凉血祛风。主治月经不调、经闭症瘕、产后乳肿、皮肤瘙痒.《本草衍义补遗》:凌霄花,治血中痛之要药也,且补阴捷甚,盖有守而独行,妇人方中多用何哉。《南宁市药物志》:有消炎解毒、止血止痛、排脓生肌之功,治红白痢。
鸡血藤性苦、甘,温。归肝、肾经,补血,活血,通络。用于月经不调,血虚萎黄,麻木瘫痪,风湿痹痛活血舒筋;养血调经,《本草纲目拾遗》载其能医手足麻木;肢体瘫痪;风湿痹痛;凌霄花,鸡血藤内服是治疗血淤不散,养血化淤活血的良药。
紫草性寒,味甘、成。归心、肝经。主治凉血,活血,解毒透疹。用于血热毒盛、斑疹紫黑、麻疹不透、疮疡、真菌性皮肤病、水火烫伤。清热凉血,用于麻疹,热病癍疹,真菌性皮肤病,尿血,血淋,血痢,疮疡,解丹毒。《本草正义》载:紫草,气味苦寒,而色紫入血,故清理血分之热。古以治脏腑之热结,后人则专治痘疡,而兼疗癍疹,皆凉血清热之正旨。
千里光,又名九里明、九里光。拉丁名称HerbaSenecionisScandentis。是一种中草药,生于山坡、疏林下、林边、路旁、沟边草丛中。其性寒,味苦,具有清热解毒,明目,止痒等功效。多用于风热感冒、目赤肿痛、泄泻痢疾、皮肤湿疹疮疖。《本草拾遗》:主疫气,结黄,疟瘴,盅毒,煮服之吐下,亦捣敷疮、虫蛇犬等咬伤处。
紫花地丁苦、辛、寒,无毒;归心、肝经。功能主治:可入药,其性寒味微苦,清热解毒,凉血消肿。主治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎;外敷治跌打损伤、痈肿、毒蛇咬伤等。紫花地丁多用于热毒壅盛之时,不但可以配合备注中所说的银花、连翘、野菊花等药材同用,更可与败酱草和黄芪同用,不但加强紫花地丁的消肿、治痈等效力时还起到一个托毒的功效。可谓之一举两得啊。紫花地丁在试管内有抑制结核杆菌生长的作用。直接镜检法和试管培养法表明:紫花地丁(醇提物31mg/ml,水煎剂62mg/ml)对钩端螺旋体有抑制作用。紫花地丁水浸剂(1∶4)在试管内对堇色毛癣菌有抑制作用。此外,认为紫花地丁尚有清热、消肿、消炎等作用。
蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植物。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值。其中含有的胡萝卜素和C及矿物质,对消化不良、便秘都有改善的作用。另外叶子还有改善湿疹、舒缓皮肤炎的功效,根则具有消炎作用,花朵煎成药汁可以去除雀斑。
艾叶,该品为菊科植物艾ArtemisiaargyiLevl.etVant.的干燥叶。夏季花未开时采摘,除去杂质,晒干。主治吐血;衄血;吃力血;便血;崩漏;妊娠下血;月经不调;痛经;胎动不安;心腹冷痛;泄泻久痢;霍乱转筋;带下;湿疹;疥癣;痔疮;痈疡。散寒止痛,温经止血。用于少腹冷痛,经寒不调,宫冷不孕,吐血,衄血,崩漏经多,妊娠下血;外治皮肤瘙痒,脱皮。醋艾炭温经止血。用于虚寒性出血。《本草纲目》载其理气血,逐寒湿;温经,止血,安胎。治心腹冷痛,泄泻转筋,久痢,吐衄,下血,月经不调,崩漏,带下,胎动不安,痈疡,疥癣。
蛇床子性辛、苦,温;有小毒。归肾经。主治温肾壮阳,燥湿,祛风,杀虫。用于阳痿,宫冷,寒湿带下,湿痹腰痛;外治外阴湿疹,妇人阴痒;阴囊湿疹,是妇科外用良药。《本草经疏》载:蛇床子,味苦平;《别录》辛甘无毒;今详其气味,当必兼温燥,阳也。故主妇人阴中肿痛,男子阴痿湿痒,除痹气,利关节,恶疮。《别录》温中下气,令妇人子服热,男子阴强,令人有子。盖以舌能除湿,温能散寒,辛能润肾,甘能益脾,故能除妇人男子一切虚寒湿所生病。寒湿既除,则病去,性能益阳,故能已疾,而又有补益也
苍术燥湿健脾,祛风散寒,明目。用于脘腹胀满,泄泻水肿,脚气痿蹙,风湿痹痛,风寒感冒,夜盲。苍术具有燥湿健脾,祛风湿的功效。主治湿阻中焦,风寒湿痹,脚膝肿痛,痿软无力,雀目夜盲。《珍珠囊》日:“能健胃安脾,诸湿肿非此不能除。”《本草纲目》曰:“治湿痰留饮......及脾湿下流,浊沥带下,滑泻肠风。”《新修本草》称其能“利小便”。
实施例1:本发明洗液的制作过程为:将百部1000g,黄柏1000g,苦参1000g,地肤子1000g,白藓皮1000g,当归1000g,千里光1000g,土茯苓1000g,凌霄花1000g,紫草1000g,益母草1000g,紫花地丁1000g,鸡血藤1000g,蛇床子1000g,黄花败酱草1000g,黄芩1000g,蒲公英1000g;先将所述原料药粉碎成粗粉,再进一步粉碎,过100目筛,使能通过100目筛的细粉量在达到30%,收集通过100目筛的细粉得细粉a;再将不能通过100目筛的粗粉投入多功能提取罐提取两次,第一次加8-10倍量乙醇煎煮1-2小时,第二次加4-8倍量水煎煮1-2小时,合并两次煎液,过滤得滤液;加热浓缩至糊状,再将白及1000g、苍术1000g和艾叶1000g蒸馏法汽化成白色结晶,干燥成粉末,加入制备的细粉a与粗颗粒提取液b,水浴搅拌均匀,混合成粘稠的液体,加入5%甲硝锉溶液中,搅拌均匀,紫外线杀菌消毒后装罐。
实施例2:本发明洗液的制作过程还可以为:将百部1000g,黄柏1000g,苦参1000g,地肤子1000g,白藓皮1000g,当归1000g,千里光1000g,土茯苓1000g,凌霄花1000g,紫草1000g,益母草1000g,紫花地丁1000g,鸡血藤1000g,蛇床子1000g,黄花败酱草1000g,黄芩1000g,蒲公英1000g,混合,切碎,浸泡。将将浸泡好的原料药加热回流提取2次,每次1~2小时,将2次提取液合并静置。再将上述水提取过的药渣加5~8倍量60~70%乙醇加热回流提取2次,每次1~2小时,将2次提取液合并静置。将上述两种提取液合并,减压浓缩相对密度为1.35(80℃)的滤液,回收乙醇,将所得滤液调整比重到1.06,减压得浸膏,将白及1000g、苍术1000g和艾叶1000g蒸馏法汽化成白色结晶粉末,再将5%甲硝锉溶液50℃~60℃加热融化,加入制备得到的浸膏和白色粉末,水浴搅拌均匀,混合成粘稠的液体,灌注,紫外线杀菌消毒后使用。
实施例3:本发明洗液的制备方法也可以为:百部1500g,黄柏1500g,苦参1300g,地肤子1400g,白藓皮1200g,当归1300g,千里光1400g,土茯苓1400g,凌霄花1400g,紫草1500g,益母草1500g,紫花地丁1400g,鸡血藤1300g,蛇床子1400g,黄花败酱草1400g,黄芩1300g,蒲公英1300g,加入5-10倍量的水浸泡1-2小时,提取2次;加热提取1-2小时,浓缩至浸膏状,成为组份1;剩余药渣加60-90%乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩,80-160目滤过,6000-10000转/分钟离心后的上清液,经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为1.35(80℃)的浸膏,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置成浸膏状,作为组份2。再将白及1300g、苍术1200g和艾叶1400g蒸馏法汽化成白色结晶粉末,再将5%甲硝锉溶液50℃~60℃加热融化,加入制备得到的浸膏,水浴搅拌均匀,混合成粘稠的液体,灌注紫外线杀菌消毒后使用。
实施例4:取百部1300g,黄柏1400g,苦参1300g,地肤子1400g,白藓皮1200g,当归1300g,千里光1400g,土茯苓1400g,凌霄花1400g,紫草1500g,益母草1500g,紫花地丁1400g,鸡血藤1300g,蛇床子1400g,黄花败酱草1400g,黄芩1300g,蒲公英1300g,白及1300g、苍术1200g和艾叶1400g加水煎煮2次,合并煎液,去除沉渣,上清液加入乙醇并过滤,滤液回收乙醇至净,最后用纯化水调整药液体积至每毫升药液相当于1g原药材,药液为黄褐色至棕褐色液体,有明显香气。
治疗采取外洗或坐浴,每次20~30mL,每日2次。一般以10d为1疗程,2~3个疗程后观察疗效。
以上所述,仅是本发明的较佳实施例而已,并非是对本发明作其它形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更或改型为等同变化的等效实施例。但是凡是未脱离本发明技术方案内容,依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与改型,仍属于本发明技术方案的保护范围。
Claims (2)
1.一种治疗妇科炎症的外用中药洗液,其特征在于,所述洗液中各种原料药的重量份数为:百部10~15份,黄柏10~15份,苦参10~15份,地肤子10~15份,白藓皮10~15份,当归10~15份,千里光10~15份,土茯苓10~15份,凌霄花10~15份,紫草10~20份,白及10~20份,益母草10~20份,紫花地丁10~20份,鸡血藤10~20份,蛇床子10~20份,黄花败酱草10~20份,黄芩10~20份,艾叶10~20份,蒲公英10~20份,苍术10~20份。
2.根据权利要求1所述治疗妇科炎症的外用中药洗液,其特征在于,所述洗液中各种原料药的重量份数为:百部10~15份,黄柏10~15份,苦参10~15份,地肤子10~15份,白藓皮10~15份,当归10~15份,千里光10~15份,土茯苓10~15份,凌霄花10~15份,紫草10~15份,白及10~15份,益母草10~15份,紫花地丁10~15份,鸡血藤10~15份,蛇床子10~15份,黄花败酱草10~15份,黄芩10~15份,艾叶10~15份,蒲公英10~15份,苍术10~15份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510848120.1A CN105381352A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的外用中药洗液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510848120.1A CN105381352A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的外用中药洗液 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105381352A true CN105381352A (zh) | 2016-03-09 |
Family
ID=55414527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510848120.1A Pending CN105381352A (zh) | 2015-11-28 | 2015-11-28 | 一种治疗妇科炎症的外用中药洗液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105381352A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105998974A (zh) * | 2016-06-28 | 2016-10-12 | 深圳市纯原上品文化传播有限公司 | 一种治疗妇科炎症的中药组合物、凝胶剂及其制备方法 |
CN106377608A (zh) * | 2016-09-29 | 2017-02-08 | 武汉安孕堂生物科技有限公司 | 妇科中药洗液 |
CN107582938A (zh) * | 2017-10-23 | 2018-01-16 | 合肥卡迪尔化妆品有限公司 | 妙薰液 |
CN107693726A (zh) * | 2017-08-15 | 2018-02-16 | 蓝浩然 | 一种治疗妇科炎症的中药组合物 |
CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
-
2015
- 2015-11-28 CN CN201510848120.1A patent/CN105381352A/zh active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105998974A (zh) * | 2016-06-28 | 2016-10-12 | 深圳市纯原上品文化传播有限公司 | 一种治疗妇科炎症的中药组合物、凝胶剂及其制备方法 |
CN106377608A (zh) * | 2016-09-29 | 2017-02-08 | 武汉安孕堂生物科技有限公司 | 妇科中药洗液 |
CN107693726A (zh) * | 2017-08-15 | 2018-02-16 | 蓝浩然 | 一种治疗妇科炎症的中药组合物 |
CN107582938A (zh) * | 2017-10-23 | 2018-01-16 | 合肥卡迪尔化妆品有限公司 | 妙薰液 |
CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145111B (zh) | 一种治疗霉菌性阴道炎的中药组合物及其制备方法 | |
CN102145064B (zh) | 一种治疗老年性阴道炎的中药组合物及其制备方法 | |
CN102205026B (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN105343625A (zh) | 一种排毒除湿利胆的蒲公英口服液及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103690853B (zh) | 一种治疗湿烂型脚癣的中药制剂及其制备方法 | |
CN101869626B (zh) | 中药复方制剂舒阴液及其制备与应用 | |
CN105381352A (zh) | 一种治疗妇科炎症的外用中药洗液 | |
CN103800772A (zh) | 一种防治阴道炎症的妇科外用洗液及其制备方法 | |
CN103041173A (zh) | 一种治疗皮炎、湿疹的中药外用制剂及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性阴道炎的中药组合物及其制备方法 | |
CN101455738A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN102058715B (zh) | 一种治疗慢性前列腺炎的中药制剂及其制备方法 | |
CN104815192A (zh) | 一种治疗高血压的药物组合物及其应用 | |
CN102988675B (zh) | 一种治疗慢性前列腺炎的中药组合物及其制备方法 | |
CN103721139A (zh) | 一种治疗龟头炎的中药组合物及其制备方法 | |
CN103041247B (zh) | 一种治疗阴道炎的中药栓剂及其制备方法 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN101433655B (zh) | 一种治疗阴道炎的中药组合物 | |
CN101391065B (zh) | 一种用于治疗急慢性盆腔炎的木鳖子花椒汤 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN105362839A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN104189413A (zh) | 用于治疗乌龟肠胃炎病的药物组合物及其制备方法 | |
CN103041263B (zh) | 一种治疗慢性前列腺炎的中药直肠给药栓剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160309 |